Shenzhen Yilifang biotechnology Co., ltd.
Detection of genetic diseases, detection of infectious diseases of the respiratory tract, detection of tumor early or prognosis, detection of karyotype analysis

New products

Yilifang meters of bi♣™ological long-term focus on re technology re←≤♠search and development, pro← mote the transformation of scientific and ≤•¥technological achievements with an open mind, and↓↔§ enhance the ability of scientific ≥∞βand technological value creation. Now it has <≤‌ a large number of high-quali>‌★Ωty technical professionals, including nearly δ↓10 doctors and masters, with stro‌$β↔ng technical force and advanced×λ✔₹ development ability. In the face of long-term ←‌'and sudden public health problems, we continue">"© to strive to develop all kinds of the latest σ÷✘and most comprehensive products.

Birth Defect Detection

China is a large populated ♦§country with a high incidence of b∑γ±irth defects. According to the "China Birth Def→↕←λects Prevention Report (2012)" released by the f↕←₩ormer Ministry of Health in September 2012✘✘ , the current incidence of birth d$§efects in China is about 5.6%, and t₽¥☆here are about 900,00✘∏∑∏0 new birth defects each year. Amo÷≠♥ng them, there are about 250,000 birth defectΩ¥s that are clinically visible at birth.  ✘↕☆"Early detection, early prevention, early tre®♠♦atment" is the guiding p∏✘rinciple of the prevention and tr‍ε≥eatment of birth defects. The purpose of carryin<™g out genetic testin₩♠₩☆g is to prevent birth defects ×♣from the source. We launched a se ≥↔♦ries of products in the coλ↑∑ntext of the new era to achieve: ε∏high science, high c∏±$overage, high suitability, high α®✔accuracy, high quality, and high cost-effec★♣•tive.

Respiratory Infections

The detection of respiratory pathogens is oΩ∑γ¥ne of the main production lines of Ecuador. The c​βompany was aware of the harm♥↔¥↕fulness and urgency of the disease society at<φ∑ε the beginning of the company's establishme§↑nt, and organized several major ∑£λ∏technical breakthroughs and double-chain fσ <¶usion project declarations≥↕. After several years of inten₹♦sive cultivation, respiratory infection detectio♥✔×£n has formed a systematic product layout and e<&>↔stablished a core technology pla☆•tform. Currently, it has developed d☆β 'etection kits for more than 20 common respira↔↕tory pathogens, and also developed P$✘₽∞OCT rapid detection and accurate Nucleic ac↕βid detection, multi-target detection and sin★±α"gle-target detection, better complement each o¶¥δ®ther, to achieve the best clin™÷€ical use and public health prevention an✔✔σ d control.

Tumor Detection

Tumors are a genomic disease. The ≤÷≈occurrence of tumors begins with genetic×®© mutations, and genetic testiσ¶α↑ng is the personalized treatment of tumors—a new'♠• era of precision medicine. ≠"₩Precision medicine is the latest med∑ ical model developed on the basis of d™∞ata from the Human Genome Project and ₹→£☆the results of eviden≈γ'≥ce-based medicine. Sex and effectiveness, to a€♦∏₹void adverse reactions, is the mos∑¶<t cutting-edge clini©™§cal practice model.

Cytogenetics (karyotyping)

The chromosome karyotype analysis is to anal∑↓ →yze the characteristics of chromosome ×✘£ length, centromere position,☆&↑‍ arm ratio, satellite size, etc. in the cells←•≤δ of the organism. After the$↑ karyotype analysis, the ca₽→✘use of the organism can be judged ba•‌sed on the variation of th←♣e chromosome structure and n★✔umber, such as the dise£♣‌•ase caused by what kind of ge∞☆→ne is missing. The major clinical₩&$♦ly relevant diseases for this test are: m≠δale Turner syndrome, mental d÷γα₽isorders associated wi<$th chromosomal abnorma✔™¥lities, mixed ovarian mixed germ cell-sexual int♥ ©"erstitial tumors, congenital o↕β≠varian hypoplasia in children, and meow synd‌♣rome in children. Signs, pediatric an±®drogen insensitivity syndrome, pediatric and★ rogenic deformity, pediatric Edwards  ‌≥←syndrome, myelodysplastic syndrome, ♣‍↓£myoclonic cerebellar coordina✔₹α♥tion disorder and so o< →Ωn.

Biochemical Reagents✘≥

Our company always adheres to the g☆↑σoal of providing custome₽φrs with suitable prod ₹ucts. Under the premise€÷Ω of developing a series of core tec ♣÷€hnology diagnostic reagents, in order to coop±≥♠erate with customers to ↑™better work and enable customers to carr$>y out work appropriately and eas✘®¥≠ily, we have also devel‍♦€×oped a series of cost-effective •↑ and high-quality Biochemical r'∏λeagents to choose from.

Equipment

Under the premise of developing a series of d¥₽∏iagnostic reagents with core te'≈chnology, our company independently develops♦☆¥≥ and manufactures correspo↑≠¶nding instruments and equipment to asπ™± sist clinical judgment.